Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The Relationships between Polymorphisms in Genes Encoding the Growth Factors TGF-β1, PDGFB, EGF, bFGF and VEGF-A and the Restenosis Process in Patients with Stable Coronary Artery Disease Treated with Bare Metal Stent.

Osadnik T, Strzelczyk JK, Reguła R, Bujak K, Fronczek M, Gonera M, Gawlita M, Wasilewski J, Lekston A, Kurek A, Gierlotka M, Trzeciak P, Hawranek M, Ostrowska Z, Wiczkowski A, Poloński L, Gąsior M.

PLoS One. 2016 Mar 1;11(3):e0150500. doi: 10.1371/journal.pone.0150500. eCollection 2016.

2.

The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.

Osadnik T, Strzelczyk JK, Lekston A, Reguła R, Bujak K, Fronczek M, Gawlita M, Gonera M, Wasilewski J, Szyguła-Jurkiewicz B, Gierlotka M, Gąsior M.

BMC Cardiovasc Disord. 2016 Nov 11;16(1):218.

3.

Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.

Osadnik T, Strzelczyk JK, Fronczek M, Bujak K, Reguła R, Gonera M, Gawlita M, Kurek A, Wasilewski J, Lekston A, Gierlotka M, Hawranek M, Ostrowska Z, Wiczkowski A, Poloński L, Gąsior M.

Adv Med Sci. 2016 Sep;61(2):276-281. doi: 10.1016/j.advms.2016.03.006. Epub 2016 Mar 28.

PMID:
27162064
4.
5.

Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.

Chen HJ, Mo N, Zhang YF, Su GZ, Wu HD, Pei F.

Int Heart J. 2018 Jan 27;59(1):161-169. doi: 10.1536/ihj.17-190. Epub 2018 Jan 15.

6.

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

Bagyura Z, Kiss L, Hirschberg K, Berta B, Széplaki G, Lux Á, Szelid Z, Soós P, Merkely B.

Dis Markers. 2017;2017:9548612. doi: 10.1155/2017/9548612. Epub 2017 Mar 7.

7.

The Relationship between VEGFA and TGFB1 Polymorphisms and Target Lesion Revascularization after Elective Percutaneous Coronary Intervention.

Osadnik T, Lekston A, Bujak K, Strzelczyk JK, Poloński L, Gąsior M.

Dis Markers. 2017;2017:8165219. doi: 10.1155/2017/8165219. Epub 2017 Jul 24.

8.

The T29C (rs1800470) polymorphism of the transforming growth factor-β1 (TGF-β1) gene is associated with restenosis after coronary stenting in Mexican patients.

Fragoso JM, Zuñiga-Ramos J, Arellano-González M, Alvarez-León E, Villegas-Torres BE, Cruz-Lagunas A, Delgadillo-Rodriguez H, Peña-Duque MA, Martínez-Ríos MA, Vargas-Alarcón G.

Exp Mol Pathol. 2015 Feb;98(1):13-7. doi: 10.1016/j.yexmp.2014.11.007. Epub 2014 Nov 13.

PMID:
25449332
9.

Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.

Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.

Chin Med J (Engl). 2013 Mar;126(6):1019-25.

PMID:
23506572
10.

Functional polymorphism rs710218 in the gene coding GLUT1 protein is associated with in-stent restenosis.

Osadnik T, Strzelczyk J, Bujak K, Reguła R, Wasilewski J, Fronczek M, Kurek A, Gawlita M, Gonera M, Gierlotka M, Lekston A, Hawranek M, Myrda K, Wiczkowski A, Ostrowska Z, Gąsior M, Poloński L.

Biomark Med. 2015;9(8):743-50. doi: 10.2217/bmm.15.36. Epub 2015 Jun 8.

PMID:
26050557
11.

Correlations of EGF G1380A, bFGF C754G and VEGF T460C polymorphisms with malignant melanoma susceptibility and prognosis: A case-control study.

Wang XH, Long ZW.

Gene. 2017 Jun 20;617:44-53. doi: 10.1016/j.gene.2017.02.023. Epub 2017 Feb 17.

PMID:
28219779
12.

Polymorphisms of TGFβ-1 and TGFBR2 in relation to coronary artery disease in a Chinese population.

Yang M, Zhu M, Tang L, Zhu H, Lu Y, Xu B, Jiang J, Chen X.

Clin Biochem. 2016 Aug;49(12):873-8. doi: 10.1016/j.clinbiochem.2016.05.022. Epub 2016 May 24.

PMID:
27234600
13.

An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents.

Katsaros KM, Kastl SP, Krychtiuk KA, Hutter R, Zorn G, Maurer G, Huber K, Wojta J, Christ G, Speidl WS.

EuroIntervention. 2014 Jun;10(2):224-30. doi: 10.4244/EIJV10I2A36.

14.

[Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].

Yang Y, Guo SX, Yang ZY, Zhang T, Cao HM, Wang RX.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Aug;30(4):456-60. doi: 10.3760/cma.j.issn.1003-9406.2013.04.017. Chinese.

PMID:
23926016
15.

Genetic risk for restenosis after coronary stenting.

Oguri M, Kato K, Hibino T, Yokoi K, Segawa T, Matsuo H, Watanabe S, Nozawa Y, Murohara T, Yamada Y.

Atherosclerosis. 2007 Oct;194(2):e172-8. Epub 2007 Feb 1.

PMID:
17275003
16.

High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.

Bagyura Z, Kiss L, Berta B, Szilágyi Á, Hirschberg K, Széplaki G, Lux Á, Szelid Z, Soós P, Merkely B.

BMC Cardiovasc Disord. 2017 Jan 5;17(1):4. doi: 10.1186/s12872-016-0440-y.

17.

Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.

Kurtul A.

Clin Appl Thromb Hemost. 2018 May;24(4):589-595. doi: 10.1177/1076029617716769. Epub 2017 Jul 4.

PMID:
28675046
18.

Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.

Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C; under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003479. doi: 10.1161/CIRCINTERVENTIONS.115.003479.

PMID:
27412868
19.

Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.

Shim CY, Park S, Yoon SJ, Park HY, Kim HT, Oh B, Park C, Ko YG, Choi D, Jang Y, Chung N.

Cardiology. 2007;107(4):261-8. Epub 2006 Sep 4.

PMID:
16954682
20.

Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.

Rittger H, Wöhrle J, Brachmann J, Hohenforst-Schmidt W, Schlundt C, Lonke S, von Cranach M, Markovic S, Achenbach S, Waliszewski M.

Catheter Cardiovasc Interv. 2016 Oct;88(4):529-534. doi: 10.1002/ccd.26451. Epub 2016 Feb 19.

PMID:
26893095

Supplemental Content

Support Center